Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,368Revenue $M4.1Net Margin (%)-1,122.4Z-Score64.3
Enterprise Value $M1,253EPS $-0.7Operating Margin %-1,128.4F-Score4
P/E(ttm))0Cash Flow Per Share $-0.6Pre-tax Margin (%)-1,122.4Higher ROA y-yY
Price/Book9.710-y EBITDA Growth Rate %2.6Quick Ratio13.2Cash flow > EarningsY
Price/Sales3385-y EBITDA Growth Rate %33.2Current Ratio13.2Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-31.7Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-34.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M82.8ROI % (ttm)-45.4Gross Margin Increase y-yN

Gurus Latest Trades with EXAS

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
EXASGeorge Soros 2014-03-31 Buy 0.03%$11.75 - $14.82
($13.45)
$ 16.8425%New holding, 200000 sh.200,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

EXAS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
EXAS George Soros 2014-03-31200,0000.240.03New Buy
Premium Most recent portfolio changes are included for Premium Members only!


EXAS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Megan William J.SVP, Finance & PFO 2014-05-05Buy10,000$11.7942.83view
Conroy Kevin TPresident and CEO 2014-02-24Sell8,708$14.0719.69view
ARORA MANEESHCOO 2014-02-24Sell2,662$14.0719.69view
LIDGARD GRAHAM PETERSr. VP, Chief Science Officer 2014-02-24Sell3,160$14.0719.69view
Conroy Kevin TPresident and CEO 2014-01-02Sell26,379$11.9640.8view
LIDGARD GRAHAM PETERSr. VP, Chief Science Officer 2014-01-02Sell10,288$11.9640.8view
ARORA MANEESHCOO 2014-01-02Sell8,627$11.9640.8view
LIDGARD GRAHAM PETERSr. VP, Chief Science Officer 2013-10-28Sell7,430$11.0752.12view
CRAWFORD SALLYDirector 2013-09-20Sell25,000$12.1938.15view
ARORA MANEESHCOO and CFO 2012-11-02Buy1,000$9.0486.28view

Press Releases about EXAS :

    Quarterly/Annual Reports about EXAS:

    News about EXAS:

    Articles On GuruFocus.com
    Meridian Funds Comments on Exact Sciences Corp Jun 20 2014 
    comment on EXAS May 12 2013 
    comment on EXAS May 12 2013 
    comment on EXAS May 12 2013 
    Weekly CEO Buys Highlight: BFS, FL, BGC, AMCF, and EXAS Nov 28 2010 
    EXACT Sciences Corp. (EXAS) CEO Kevin T Conroy buys 6,000 Shares Nov 23 2010 
    EXACT Sciences Corp. (EXAS) CFO Maneesh Arora buys 2,500 Shares Aug 20 2010 
    cooldecency99 note on EXAS May 01 2010 
    Weekly CFO Buys Highlight: Heska Corp., Apollo Investment Corp., EXACT Sciences Corp., Innospec Inc. Feb 28 2010 
    Exact Sciences Reports Second-Quarter 2009 Financial Results Aug 12 2009 

    More From Other Websites
    Amidst Ongoing Doubts, Exact Sciences Still Offers Opportunity Jul 23 2014
    Exact Sciences Reports Second-Quarter 2014 Financial Results Jul 22 2014
    Exact Sciences Reports Second-Quarter 2014 Financial Results Jul 22 2014
    Q2 2014 EXACT Sciences Corporation Earnings Release - 10:00 am ET Jul 22 2014
    [video] Shares of Air Lease, II-VI Inc. & Exact Sciences Shares Set To Fly Higher Jul 16 2014
    Exact Sciences to host second-quarter 2014 results, annual meeting webcasts and calls Jul 16 2014
    Exact Sciences to host second-quarter 2014 results, annual meeting webcasts and calls Jul 16 2014
    Turn Bird's-Eye View Into A Ground-Level Plan Jul 11 2014
    EXACT Sciences (EXAS) is Overbought: Is A Drop Coming? Jun 20 2014
    Exact Sciences to Participate in Goldman Sachs Global Healthcare Conference Jun 05 2014
    Wednesday's Top Upgrades (and Downgrades) Jun 04 2014
    Exact Sciences to Participate in June Investor Conferences May 28 2014
    Exact Sciences: Misunderstood And Undervalued? May 28 2014
    Exact Sciences Is A Compelling Long May 12 2014
    EXACT SCIENCES CORP Financials May 09 2014
    Exact Sciences to Participate in May Investor Conferences May 05 2014
    EXACT SCIENCES CORP Files SEC form 10-Q, Quarterly Report May 02 2014
    EXACT Sciences Corporation Discusses Q1 2014 Results (Webcast) May 01 2014
    Exact Sciences Reports First-Quarter 2014 Financial Results May 01 2014
    Q1 2014 EXACT Sciences Corporation Earnings Release - Before Market Open May 01 2014
    Exact Sciences Announces FDA Advisory Committee Unanimously Recommends Approval of Cologuard Mar 27 2014
    Exact Sciences' Stock Trading Halted Today; FDA Advisory Committee Meeting to Review Premarket... Mar 27 2014
    Exact Sciences Announces Appointment of Kevin Conroy as Chairman of the Board; David Thompson to... Mar 21 2014
    Exact Sciences' DeeP-C Study Results Published in New England Journal of Medicine Mar 19 2014
    Exact Sciences to Participate in ROTH Conference Mar 03 2014
    Exact Sciences Reports Fourth-Quarter and Full-Year 2013 Financial Results Feb 20 2014
    Exact Sciences to Host Fourth-Quarter 2013 Results Webcast and Call Feb 10 2014
    U.S. Food and Drug Administration confirms date for Exact Sciences' advisory committee Feb 05 2014
    Exact Sciences to participate in Leerink Swann Global Healthcare Conference Feb 04 2014
    Exact Sciences to Participate in J.P. Morgan Healthcare Conference Jan 06 2014
    Exact Sciences Announces Date for FDA Advisory Committee Meeting Dec 03 2013
    Exact Sciences Reports Third-Quarter 2013 Financial Results Oct 29 2013

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide